Full history for every metric is available with a Kvantra account
Biocorp Production (ALCOR.PA)
Key financial summary
Financials in EUR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 2 | 4 | 8 | 8 | 10 | 12 | 8 |
| Operating profit | €m | -1 | 1 | |||||
| Net profit | €m | -8 | -5 | 1 | -1 | 0 | -1 | 1 |
| EPS reported | € | -0.15 | 0.23 | |||||
| Operating cashflow per share | € | -0.05 | -0.05 | |||||
| Capex per share | € | 0.22 | 0.22 | |||||
| FCF per share | € | -0.27 | -0.27 | |||||
| Free cash flow | €m | -1 | 1 | |||||
| Net debt | €m | 3 | 3 | |||||
| Book value equity | €m | 2 | 2 | |||||
| Book value per share | € | 0.56 | 0.59 | |||||
| Number of shares | m | 4.4 | 4.15 | |||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 39.51 | 62.80 | |||||
| P/S LTM | x | 8.33 | 18.29 | |||||
| P/FCF LTM | x | -82.20 | 168.18 | |||||
| EV/EBITDA LTM | x | 6,093.79 | 97.32 | |||||
| EV/Sales LTM | x | 8.60 | 18.66 | |||||
| Earnings Yield LTM | % | -0.67% | -0.42% | |||||
| FCF Yield | % | -1.22% | 0.59% | |||||
| Quality | ||||||||
| ROE | % | -26.47% | -23.33% | |||||
| ROIC | % | -5.29% | -5.29% | |||||
| Operating margin | % | -6.27% | -6.27% | |||||
| Gross margin | % | 50.89% | 50.89% | |||||
| FCF/Sales | % | -10.13% | -10.13% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +14.13% | +117.14% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.20 | 0.16 | |||||
| Net Debt/EBITDA | x | 188.75 | 188.75 | |||||
| EBIT/Net interest | x | -11.88 | -11.88 | |||||
| Net debt/market cap | % | 3.20% | 2.01% | |||||
| Net debt/Equity | x | 1.26 | 1.26 | |||||
| Gross debt/equity | x | 2.35 | 2.35 | |||||
Company overview
Based in Issoire, France, Biocorp Production, established in 2004, specializes in the innovation and production of medical devices and advanced drug delivery systems. The company offers a suite of intelligent products, such as Inspair, a smart cap designed to track inhaler usage, and Mallya, an intelligent cap for pen injectors that logs vital injection details. Its portfolio also features motor-driven solutions like Onejet, a single-use auto-injector engineered for administering high-viscosity medications, and the Datapen pen injector. Furthermore, Injay serves as a data collection tool, compiling critical information including injection completion, date and time, drug type, batch identifiers, and expiration dates. Biocorp's offerings extend to other pharmaceutical aids, such as NEWGUARD, a safety apparatus for various prefilled syringe sizes, the needle-integrated BIOPASS reconstitution system, and diverse closure mechanisms.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Biocorp Production (ALCOR.PA)
Based in Issoire, France, Biocorp Production, established in 2004, specializes in the innovation and production of medical devices and advanced drug delivery systems. The company offers a suite of intelligent products, such as Inspair, a smart cap designed to track inhaler usage, and Mallya, an intelligent cap for pen injectors that logs vital injection details. Its portfolio also features motor-driven solutions like Onejet, a single-use auto-injector engineered for administering high-viscosity medications, and the Datapen pen injector. Furthermore, Injay serves as a data collection tool, compiling critical information including injection completion, date and time, drug type, batch identifiers, and expiration dates. Biocorp's offerings extend to other pharmaceutical aids, such as NEWGUARD, a safety apparatus for various prefilled syringe sizes, the needle-integrated BIOPASS reconstitution system, and diverse closure mechanisms.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free